Serum insulin and C-peptide concentration and breast cancer: a meta-analysis (Q44072087)

29 November 2017

0 references

Serum insulin and C-peptide concentration and breast cancer: a meta-analysis (English)

1 reference

29 November 2017

1 reference

1

1 reference

29 November 2017

2

1 reference

29 November 2017

3

1 reference

29 November 2017

4

1 reference

29 November 2017

7

1 reference

29 November 2017

6

Julio Rosenstock

1 reference

29 November 2017

5

Geremia Bolli

1 reference

29 November 2017

14 February 2013

1 reference

29 November 2017

Cancer Causes & Control

1 reference

29 November 2017

24

1 reference

29 November 2017

873-883

1 reference

29 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-013-0164-6

29 November 2017

0 references

cites work

Cancer risk in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

IGF and insulin receptor signaling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Hyperinsulinemia in colon, stomach and breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Serum levels of leptin, insulin, and lipids in relation to breast cancer in china

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Relation between insulin resistance and breast cancer among Chilean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Insulin resistance and breast carcinogenesis: a cross-sectional study among Iranian women with breast mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Prospective study on the role of glucose metabolism in breast cancer occurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Insulin resistance and breast-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Serum insulin-like growth factor-I and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

Conducting Meta-Analyses in R with the metafor Package

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0164-6

10.1007/S10552-013-0164-6

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

23408243